EXtending the tIme Window of Thrombolysis by ButyphThalide up to 6 Hours After Onset (EXIT-BT)

Clinical trial NCT05189509 · COMPLETED

Trial details

NCT number: NCT05189509
Sponsor: General Hospital of Shenyang Military Region
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stroke, Ischemic

Start date: 2022-02-11
Primary completion: 2022-09-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.